 |
|
|
| |
Change in Healthcare Professionals' Identification, Counseling, and Adherence With Black Women for Long-Acting Cabotegravir (CAB LA) for PrEP Across Women's Health, Primary Care, and Infectious Diseases Sites: Findings From the EBONI Study
|
| |
| |
IDWeek 2024; October 16-19, 2024; Los Angeles, CA
Dylan M. Baker1, Katherine L. Nelson2, Satish Mocherla3, Yolanda Lawson4, Alftan Dyson2, Deanna Merrill2, Lisa Petty2, Peter Jeffery5, Kenneth Sutton2, Sara M. Andrews6, Samantha Chang6, Kimberley Brown2, Maggie Czarnogorski2, Nanlesta Pilgrim2
1Emory University School of Medicine, Atlanta, GA, United States; 2ViiV Healthcare, Durham, NC, United States; 3Legacy Community Health, Houston, TX, United States; 4Abounding Prosperity, Inc., Dallas, TX, United States; 5GSK, London, United Kingdom; 6RTI International, Research Triangle Park, NC, United States
|
| |
|
|
|
|
|
